The most significantly differentially expressed gene was BGN (FDR 1.7x10-100), which encodes a small extracellular matrix protein biglycan (28), with 474-fold upregulation in dormant versus proliferating cancer cells (Figure 1H). This evidence concerns the gene BGN and cancer.